Biofilm-associated metabolism via ERG251 in Candida albicans
PLOS Pathogens · 2024
DOI: 10.1371/journal.ppat.1012225 ↗Kurz gefasst
Fachartikel in der Zeitschrift PLOS Pathogens, 2024. Verfasst von Liping Xiong und 8 weiteren Autor:innen. Beteiligte Einrichtung: Department of Microbiology, University of Georgia, Athens, Georgia, United States of America. Hauptthemen laut MEDLINE: Biofilms, Candida albicans, Fungal Proteins, Candidiasis. Die Arbeit wurde bisher 20-mal zitiert (Crossref) und nennt 64 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: BLRD VA, NIAID NIH HHS, NIH/NIAID.
Abstract (Originalsprache)
Biofilm formation by the fungal pathogen Candida albicans is the basis for its ability to infect medical devices. The metabolic gene ERG251 has been identified as a target of biofilm transcriptional regulator Efg1, and here we report that ERG251 is required for biofilm formation but not conventional free-living planktonic growth. An erg251 Δ/Δ mutation impairs biofilm formation in vitro and in an in vivo catheter infection model. In both in vitro and in vivo biofilm contexts, cell number is reduced and hyphal length is limited. To determine whether the mutant defect is in growth or some other aspect of biofilm development, we examined planktonic cell features in a biofilm-like environment, which was approximated with sealed unshaken cultures. Under those conditions, the erg251 Δ/Δ mutation causes defects in growth and hyphal extension. Overexpression in the erg251 Δ/Δ mutant of the paralog ERG25 , which is normally expressed more weakly than ERG251 , partially improves biofilm formation and biofilm hyphal content, as well as growth and hyphal extension in a biofilm-like environment. GC-MS analysis shows that the erg251 Δ/Δ mutation causes a defect in ergosterol accumulation when cells are cultivated under biofilm-like conditions, but not under conventional planktonic conditions. Overexpression of ERG25 in the erg251 Δ/Δ mutant causes some increase in ergosterol levels. Finally, the hypersensitivity of efg1 Δ/Δ mutants to the ergosterol inhibitor fluconazole is reversed by ERG251 overexpression, arguing that reduced ERG251 expression contributes to this efg1 Δ/Δ phenotype. Our results indicate that ERG251 is required for biofilm formation because its high expression levels are necessary for ergosterol synthesis in a biofilm-like environment.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Department of Microbiology, University of Georgia, Athens, Georgia, United States of America.
- Department of Microbiology and Immunology, Stony Brook University, Stony Brook, New York, United States of America.
- Department of Medical Microbiology and Immunology, University of Wisconsin, Madison, Wisconsin, United States of America.
- Department of Biological Sciences, Carnegie Mellon University, Pittsburgh, Pennsylvania, United States of America.
ORCID-Profile: Aaron P Mitchell
Förderung
- BLRD VA
- NIAID NIH HHS
- NIH/NIAID
- University of Georgia
Zitieren
APA
Xiong, L., Pereira De Sa, N., Zarnowski, R., Huang, M. Y., Mota Fernandes, C., Lanni, F., Andes, D. R., Del Poeta, M., & Mitchell, A. P. (2024). Biofilm-associated metabolism via ERG251 in Candida albicans. PLOS Pathogens. https://doi.org/10.1371/journal.ppat.1012225
Vancouver
Xiong L, Pereira De Sa N, Zarnowski R, Huang MY, Mota Fernandes C, Lanni F, et al. Biofilm-associated metabolism via ERG251 in Candida albicans. PLOS Pathogens. 2024. doi:10.1371/journal.ppat.1012225
BibTeX
@article{Xiong2024,
author = {Xiong, Liping and Pereira De Sa, Nivea and Zarnowski, Robert and Huang, Manning Y and Mota Fernandes, Caroline and Lanni, Frederick and Andes, David R and Del Poeta, Maurizio and Mitchell, Aaron P},
title = {Biofilm-associated metabolism via ERG251 in Candida albicans},
journal = {PLOS Pathogens},
year = {2024},
doi = {10.1371/journal.ppat.1012225}
}
EUVIMED